Pevion Biotech Ltd.

City:

Bern

Country:

Switzerland

Published Applications:

Last publication date:

2014-03-13

Patent Grants:

Last grant date:

2014-05-06

Top Inventors for applications by Pevion Biotech Ltd.

These are the the leading inventors for applications assigned to Pevion Biotech Ltd.:

Rinaldo Zurbriggen 6 Schmitten, Switzerland
Silvia Rasi 3 Bern, Switzerland
Mario Amacker 2 Bern, Switzerland
Antonio Cassone 1 Roma, Italy

Rinaldo Zubriggen 1 Schmitter, Switzerland
Maria Grazia Cusi 1 Siena, Italy
Flavia De Bernardis 1 Rome, Italy
Flavia De Bernardis 1 Roma, Italy

Rinaldo Zurbriggen 1 Rainstrasse, Switzerland
Antonio Cassone 1 Rome, Italy
Morgane Bomsel 1 Paris, France
Andreas Kammer 1 Haberlimatteweg, Switzerland

Joseph Brunner 1 Olten, Switzerland
Sylvain FLEURY 1 Bottens, Switzerland
Guido Francini 1 Siena, Italy
Sonia Vadrucci 1 Zurich, Switzerland

Pierpaolo Correale 1 Siena, Italy
Andreas Kammer 1 Zollikofen, Switzerland

Recent patent applications by Pevion Biotech Ltd.

Pevion Biotech Ltd. based in Bern, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2014-03-13

US20140072616A1

Human necessities

Lyophilization of Virosomes

#2 | 2010-11-11 ✅ Patent 8,715,698 granted on 2014-05-06

US20100285109A1

Human necessities

Truncated secretory aspartyl proteinase 2

#3 | 2010-01-21 ✅ Patent 8,496,962 granted on 2013-07-30

US20100015214A1

Human necessities

Trans-adjuvant system

#4 | 2009-11-12

US20090280163A1

Human necessities

High-Efficiency Fusogenic Vesicles, Methods of Producing Them, and Pharmaceutical Compositions Containing Them

#5 | 2009-08-13 ✅ Patent 9,216,156 granted on 2015-12-22

US20090202622A1

Human necessities

Virosome-like vesicles comprising gp41-derived antigens

#6 | 2008-10-30

US20080268028A1

Human necessities

Lyophilization of virosomes

#7 | 2008-05-08

US20080107649A1

Chemistry; metallurgy

Immunogenic compositions of cyclic peptides derived from the beta-amyloid peptide

#8 | 2005-02-10 ✅ Patent 7,378,495 granted on 2008-05-27

US20050033023A1

Human necessities

PTH-rP related peptide cancer therapeutics

AssigneeID:

58096 ⎘